Supreme Petrochem Ltd
Supreme Petrochem Ltd
CommoditiesKey Fundamentals
MicrocapPetrochemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Supreme Petrochem Ltd insights
42 extracted metrics + investor summaries across FY16–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 52.4%
Weaknesses
1- The company has delivered a poor sales growth of 10.9% over past five years.
Growth Rate
AI Analysis — Bull vs Bear
Supreme Petrochem Ltd is a nearly debt-free specialty chemicals company with a market cap of ₹13,241 Cr trading at a P/E of 27.2x. While the company has delivered strong long-term stock returns (10-year CAGR of 23%) and maintains a healthy dividend payout of 52.4%, recent sales growth has stagnated at 0% over 3 years and TTM revenue declined 3%.
- Company is almost debt-free, providing financial flexibility and resilience against interest rate cycles
- Healthy dividend payout ratio of 52.4% with a current dividend yield of 1.49%, indicating shareholder-friendly capital allocation
- Strong long-term wealth creation with 10-year stock CAGR of 23% and 5-year stock CAGR of 15%
- Robust long-term profitability with 10-year compounded profit growth of 19% and 10-year average ROE of 24%
- TTM profit growth of 40% suggests a meaningful earnings recovery underway despite flat revenues
- 5-year average ROE of 23% demonstrates efficient capital deployment over extended periods
- 10-year compounded sales growth of 10% shows the company has scaled meaningfully over the long term
- TTM sales declined 3% and 3-year compounded sales growth is 0%, indicating revenue stagnation
- 3-year compounded profit growth is -12%, showing earnings erosion over the medium term despite recent TTM recovery
- ROE has deteriorated from 5-year average of 23% to last year's 14%, a significant decline in return on equity
- P/E of 27.2x appears elevated relative to the last year ROE of only 14% and flat sales growth, suggesting limited margin of safety
- P/B ratio of 5.57x is high for a chemicals company with declining returns on equity
- 5-year compounded profit growth is -7%, indicating the recent TTM recovery may not yet represent a sustained trend
- 1-year stock return of -8% reflects market skepticism about near-term growth prospects
- Poor 5-year sales growth of approximately 11% (10.9%) for a mid-cap chemicals company limits re-rating potential
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Margin normalization expected ahead Jul 30
Current 19.53% EBITDA margin described as an aberration driven by favorable styrene monomer deltas; management expects normalization over time.
- No FY27 volume guidance issued Jul 30
Management withheld FY2027 volume guidance citing uncertainty around exports, styrene availability, shipping space, and freight rates due to fluid West Asia situation.
- Q1 net profit surges 192% YoY Jul 27
Standalone net profit jumped ~192% YoY to ₹23,633.43 lakh in Q1FY27, with revenue from operations at ₹1,69,270.78 lakh.
- INR900 Cr CapEx for expansion Jul 30
Company announced ₹900 crore CapEx funded via internal accruals, including compounding capacity growth from 50,000 to 80,000 TPA by June 2027 and a new 80,000 TPA polystyrene line at Amdoshi by December 2028, lifting total PS capacity to 380,000 TPA.
- Investor meetings scheduled Aug 6-11 Aug 2
Supreme Petrochem scheduled in-person investor meetings with ASK Mutual Fund on August 6 and Takshil Financial Services on August 11, 2026.
- Q1 FY27 earnings call published Jul 29
Audio recording of the Q1 FY27 earnings conference call held on July 29, 2026 made available on company website per SEBI compliance.
- 37th AGM concluded successfully Jul 14
Shareholders approved financial statements, dividends, and director re-appointments at the 37th Annual General Meeting.
TL;DR: Supreme Petrochem delivered a stellar Q1FY27 with 192% YoY profit growth and announced aggressive capacity expansion worth ₹900 crore funded internally. However, management flagged that current high margins are unsustainable and declined to guide on FY27 volumes due to geopolitical and supply chain uncertainties. The trend is strong near-term but investors should watch for margin reversion and West Asia-related disruptions as the year progresses.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,225 | 1,278 | 1,188 | 1,563 | 1,573 | 1,506 | 1,405 | 1,539 | 1,387 | 1,100 | 1,265 | 1,587 | 1,693 |
| Expenses | 1,135 | 1,171 | 1,093 | 1,388 | 1,412 | 1,380 | 1,306 | 1,394 | 1,272 | 1,023 | 1,195 | 1,334 | 1,362 |
| Operating Profit | 90 | 106 | 95 | 175 | 161 | 125 | 99 | 145 | 115 | 78 | 69 | 253 | 331 |
| OPM % | 7% | 8% | 8% | 11% | 10% | 8% | 7% | 9% | 8% | 7% | 5% | 16% | 20% |
| Other Income | 18 | 16 | 16 | 19 | 23 | 17 | 17 | 19 | 15 | 9 | 2 | 8 | 17 |
| Interest | 1 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 |
| Depreciation | 14 | 14 | 15 | 16 | 16 | 17 | 17 | 17 | 18 | 18 | 27 | 28 | 28 |
| PBT | 94 | 106 | 92 | 177 | 164 | 122 | 96 | 143 | 109 | 65 | 40 | 229 | 317 |
| Tax % | 26% | 26% | 27% | 26% | 26% | 26% | 26% | 25% | 25% | 26% | 25% | 27% | 25% |
| Net Profit | 69 | 78 | 68 | 132 | 122 | 90 | 71 | 107 | 81 | 48 | 30 | 168 | 236 |
| EPS in Rs | 3.68 | 4.15 | 3.6 | 6.99 | 6.49 | 4.8 | 3.79 | 5.68 | 4.3 | 2.56 | 1.6 | 8.94 | 12.57 |
Profit & Loss
| Jun 2015 | Mar 2016 9m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,653 | 2,068 | 2,919 | 3,027 | 3,194 | 2,724 | 3,185 | 5,032 | 5,287 | 5,253 | 6,023 | 5,338 | 5,645 |
| Expenses | 2,559 | 1,964 | 2,621 | 2,830 | 3,100 | 2,576 | 2,511 | 4,126 | 4,626 | 4,780 | 5,488 | 4,820 | 4,914 |
| Operating Profit | 93 | 104 | 297 | 196 | 93 | 148 | 674 | 907 | 661 | 473 | 535 | 519 | 731 |
| OPM % | 3.5% | 5% | 10% | 6% | 2.9% | 5% | 21% | 18% | 12% | 9% | 9% | 10% | 13% |
| Other Income | 3 | 3 | 7 | 8 | 10 | 12 | 16 | 30 | 59 | 65 | 73 | 33 | 36 |
| Interest | 17 | 5 | 5 | 5 | 4 | 6 | 7 | 7 | 6 | 10 | 15 | 17 | 14 |
| Depreciation | 24 | 17 | 22 | 21 | 23 | 36 | 39 | 42 | 47 | 59 | 68 | 91 | 101 |
| PBT | 56 | 85 | 278 | 179 | 76 | 118 | 644 | 888 | 667 | 468 | 525 | 443 | 651 |
| Tax % | 37% | 33% | 35% | 35% | 35% | 13% | 26% | 25% | 25% | 26% | 26% | 26% | — |
| Net Profit | 36 | 57 | 179 | 116 | 49 | 103 | 477 | 663 | 498 | 346 | 391 | 327 | 483 |
| EPS in Rs | 1.85 | 2.96 | 9.3 | 6.02 | 2.55 | 5.32 | 25.4 | 35.28 | 26.49 | 18.43 | 20.77 | 17.41 | 25.67 |
| Div. Payout % | 41% | 51% | 24% | 37% | 59% | 52% | 30% | 22% | 42% | 49% | 48% | 60% | — |
Balance Sheet
| Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 96 | 96 | 96 | 96 | 96 | 96 | 94 | 38 | 38 | 38 | 38 | 38 |
| Reserves | 280 | 318 | 486 | 549 | 546 | 577 | 971 | 1,478 | 1,806 | 1,982 | 2,194 | 2,333 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 29 | 41 | 37 | 17 | 114 | 130 | 126 |
| Other Liabilities | 505 | 523 | 548 | 650 | 578 | 552 | 649 | 725 | 870 | 932 | 1,087 | 970 |
| Total Liabilities | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,467 |
| Fixed Assets | 345 | 333 | 337 | 333 | 331 | 371 | 359 | 337 | 527 | 769 | 813 | 1,474 |
| CWIP | 4 | 10 | 13 | 10 | 24 | 8 | 9 | 179 | 108 | 233 | 582 | 74 |
| Investments | 0 | 0 | 0 | 111 | 251 | 135 | 470 | 484 | 563 | 572 | 435 | 324 |
| Other Assets | 532 | 595 | 780 | 842 | 615 | 741 | 917 | 1,279 | 1,534 | 1,492 | 1,618 | 1,594 |
| Total Assets | 881 | 938 | 1,130 | 1,296 | 1,221 | 1,255 | 1,755 | 2,278 | 2,731 | 3,065 | 3,448 | 3,467 |
Cash Flow
| Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 80 | 84 | 69 | 213 | 133 | 120 | 435 | 672 | 304 | 557 | 342 | 246 |
| Investing | -5 | -5 | -25 | -15 | -27 | -8 | -64 | -140 | -147 | -182 | -330 | -190 |
| Financing | -66 | -40 | -16 | -57 | -56 | -90 | -104 | -178 | -194 | -197 | -212 | -228 |
| Net Cash Flow | 9 | 39 | 27 | 141 | 50 | 22 | 266 | 354 | -37 | 178 | -201 | -171 |
| Free Cash Flow | 73 | 77 | 41 | 194 | 101 | 104 | 413 | 509 | 98 | 245 | -36 | 37 |
| CFO/OP | 96 | 117 | 53 | 140 | 167 | 107 | 89 | 99 | 72 | 140 | 87 | 67 |
Ratios
| Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 33 | 50 | 38 | 36 | 33 | 33 | 44 | 30 | 25 | 27 | 24 | 34 |
| Inventory Days | 29 | 37 | 46 | 44 | 31 | 40 | 51 | 29 | 55 | 39 | 50 | 51 |
| Days Payable | 61 | 83 | 65 | 80 | 60 | 74 | 90 | 50 | 66 | 66 | 66 | 65 |
| Cash Conversion Cycle | 1 | 3 | 19 | 0 | 3 | 0 | 4 | 8 | 14 | 0 | 8 | 20 |
| Working Capital Days | 3 | 8 | 22 | 12 | 5 | 5 | 19 | 8 | 19 | 1 | 4 | 15 |
| ROCE % | 19% | 22% | 57% | 30% | 12% | 18% | 72% | 66% | 37% | 22% | 23% | 19% |
Documents
Frequently Asked Questions about Supreme Petrochem Ltd
What does Supreme Petrochem Ltd do?
Where is Supreme Petrochem Ltd (SPLPETRO) listed?
Which sector does Supreme Petrochem Ltd belong to?
What is the market capitalisation of Supreme Petrochem Ltd?
What is the PE ratio of Supreme Petrochem Ltd?
What is the 52-week high and low of Supreme Petrochem Ltd?
Does Supreme Petrochem Ltd pay dividends?
What is the Return on Equity (ROE) of Supreme Petrochem Ltd?
How can I research Supreme Petrochem Ltd on Tapetide?
Company Information
Supreme Petrochem Ltd (SPL) is a petrochemical company engaged in the business of manufacturing Polystyrene, Compounds of Styrenics and other Polymers. [1]